Please find attached intimation regarding ESG Rating

August 22, 2026 BSE Limited National Stock Exchange of India Limited P J Towers, Exchange Plaza, C-1, Block G, Dalal Street, Bandra Kurla Complex, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 543904 Symbol: MANKIND Dear Sir/ Madam, Subject: Intimation of Environmental, Social and Governance Rating Ref.: Regulation 30 & 51 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) Pursuant to Regulations 30 and 51 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), read with the SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, we wish to inform you that CRISIL ESG Ratings & Analytics Limited (“CRISIL ESG Ratings”), a SEBI- registered Category-I ESG Ratings Provider, has independently assigned an Environmental, Social and Governance (“ESG”) Rating of 64 to the Company, falling under the “Strong” category. This represents an improvement from the Company’s previous ESG Rating of 57, which was classified under the “Adequate” category. Further, the Company’s Core ESG Rating has also improved to 71 from the previous rating of 60. Please note that the Company has not engaged CRISIL ESG Ratings for obtaining the ESG Ratings and that it has independently prepared the report based on disclosures for FY2026 and other publicly available information about the Company. The above disclosure is also being made available on the Company’s website at www.mankindpharma.com. This is for your information and records. Thanking You, Yours Faithfully, For Mankind Pharma Limited Hitesh Kumar Jain Company Secretary & Compliance Officer